Predicting Depression and Quality of Life among Long-term Head and Neck Cancer Survivors

Abstract

Objective

The aim of this study is to identify clinical factors that are predictive of depression and quality of life (QOL) among long-term survivors of head and neck squamous cell carcinoma and to develop predictive scores using these factors.

Study Design

Cohort study

Setting

Tertiary referral center.

Subjects and Methods

A total of 209 posttreatment (median follow-up, 38.7 months) head and neck cancer patients were prospectively evaluated using the Hospital Anxiety Depression Scale (HADS), the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30, and the EORTC Quality of Life Questionnaire Head and Neck 35, and pretreatment patient-related, tumor-related, and treatment-related predictors were identified using chart review. Bivariate (χ² and t test) and multivariate (linear regression) analyses were used to construct predictive models.

Results

Significant pretreatment predictors of depression were identified on multivariate analysis as smoking at diagnosis, >14 alcoholic drinks per week, T3 or T4 status, and >3 medications (P < .001). Two or more of these factors yielded an 82.3% sensitivity in detecting significant depressive symptoms (defined as a HADS cutoff score of 5). Significant predictors of fatigue, global health/QOL, social contact, speech, pain, swallowing, and xerostomia were also identified.

Conclusion

Pretreatment predictors of long-term depression and QOL have been defined using multivariate models, and an easily applicable predictive score of long-term depression is proposed. Potential eventual clinical applications include prophylactic intervention in at-risk patients.

Keywords

quality of life depression prediction head and neck cancer score

Get full access to this article

View all access options for this article.

References

Johnson-Obaseki

McDonald

Corsten

. Head and neck cancer in Canada: trends 1992 to 2007. Otolaryngol Head Neck Surg. 2012;147:74–78.

Lassen

Eriksen

Hamilton-Dutoit

. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27:1992–1998.

Katz

Kopek

Waldron

. Screening for depression in head and neck cancer. Psychooncology. 2004;13:269–280.

Haisfield-Wolfe

McGuire

Soeken

. Prevalence and correlates of depression among patients with head and neck cancer: a systematic review of implications for research. Oncol Nurs Forum. 2009;36:E107–E125.

Sollner

DeVries

Steixner

. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling? Br J Cancer. 2001;84:179–185.

Dufy-Barbe

Bresson

Sartor

. Calcium homeostasis in growth hormone (GH)-secreting adenoma cells: effect of GH-releasing factor. Endocrinology. 1992;131:1436–1444.

Misono

Weiss

Fann

. Incidence of suicide in persons with cancer. J Clin Oncol. 2008;26:4731–4738.

Kendal

. Suicide and cancer: a gender-comparative study. Ann Oncol. 2007;18:381–387.

Bjelland

Dahl

Haug

. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res. 2002;52:69–77.

10.

Cohen

. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. 3rd ed. Mahwah, NJ; Lawrence Erlbaum Associates; 2003.

11.

Kravitz

Ford

. Introduction: chronic medical conditions and depression—the view from primary care. Am J Med. 2008;121:S1–S7.

12.

de Leeuw

de Graeff

Ros

. Prediction of depression 6 months to 3 years after treatment of head and neck cancer. Head Neck. 2001;23:892–898.

13.

Funk

Karnell

Christensen

. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012;138:123–133.

14.

Duffy

Ronis

Valenstein

. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15:2203–2208.

15.

Mitchell

. Cancer-related fatigue: state of the science. PM R. 2010;2:364–383.

16.

Schlecht

Brandwein-Gensler

Nuovo

. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol. 2011;24:1295–1305.

17.

Harrison

. Impact of anemia in patients with head and neck cancer treated with radiation therapy. Curr Treat Options Oncol. 2005;6:31–45.

18.

El-Deiry

Futran

McDowell

. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg. 2009;135:380–384.

19.

Fingeret

Yuan

Urbauer

. The nature and extent of body image concerns among surgically treated patients with head and neck cancer [published online June 27, 2011]. Psychooncology.

20.

Millsopp

Brandom

Humphris

. Facial appearance after operations for oral and oropharyngeal cancer: a comparison of casenotes and patient-completed questionnaire. Br J Oral Maxillofac Surg. 2006;44:358–363.

21.

Epstein

Emerton

Kolbinson

. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck. 1999;21:1–11.

22.

Howren

Christensen

Karnell

. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms. Health Psychol. 2010;29:65–71.

23.

Shuman

Terrell

Light

. Predictors of pain among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012;138:1147–1154.

24.

Schrag

Chang

Tsai

. Complete rehabilitation of the mandible following segmental resection. J Surg Oncol. 2006;94:538–545.

25.

Kendall

McKenzie

Leonard

. Timing of swallowing events after single-modality treatment of head and neck carcinomas with radiotherapy. Ann Otol Rhinol Laryngol. 2000;109:767–775.

26.

Wang

Eisbruch

. Organ-sparing radiation therapy for head and neck cancer. Nat Rev Clin Oncol. 2011;8:639–648.

27.

Pignone

Gaynes

Rushton

. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765–776.

28.

Loponen

Luther

Nissinen

. EuroSCORE predicts health-related quality of life after coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2008;7:564–568.

29.

Mallett

Royston

Dutton

. Reporting methods in studies developing prognostic models in cancer: a review. BMC Med. 2010;8:20.

30.

Mallett

Royston

Waters

. Reporting performance of prognostic models in cancer: a review. BMC Med. 2010;8:21.

31.

de Graeff

de Leeuw

Ros

. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110:98–106.

32.

Aarstad

Heimdal

. Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life. Acta Otolaryngol. 2005;125:557–565.

33.

Karnell

Funk

Christensen

. Persistent posttreatment depressive symptoms in patients with head and neck cancer. Head Neck. 2006;28:453–461.

34.

Singer

Krauss

Keszte

. Predictors of emotional distress in patients with head and neck cancer. Head Neck. 2012;34:180–187.

35.

de Leeuw

de Graeff

Ros

. Prediction of depressive symptomatology after treatment of head and neck cancer: the influence of pre-treatment physical and depressive symptoms, coping, and social support. Head Neck. 2000;22:799–807.

36.

Terrell

Ronis

Fowler

. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130:401–408.

37.

Lambert

Terrell

Copeland

. Cigarettes, alcohol, and depression: characterizing head and neck cancer survivors in two systems of care. Nicotine Tob Res. 2005;7:233–241.

38.

Carr

Schmidbauer

Majaess

. Communication after laryngectomy: an assessment of quality of life. Otolaryngol Head Neck Surg. 2000;122:39–43.

39.

List

Ritter-Sterr

Baker

. Longitudinal assessment of quality of life in laryngeal cancer patients. Head Neck. 1996;18:1–10.

40.

Morton

. Laryngeal cancer: quality-of-life and cost-effectiveness. Head Neck. 1997;19:243–250.

41.

Finizia

Hammerlid

Westin

. Quality of life and voice in patients with laryngeal carcinoma: a posttreatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope. 1998;108:1566–1573.

42.

Lydiatt

Denman

McNeilly

. A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008;134:528–535.

43.

Coyne

. Misleading report on the prevention of major depression among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2008;134:1345.

44.

Stockler

O’Connell

Nowak

. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol. 2007;8:603–612.

45.

Semple

Dunwoody

Kernohan

. Development and evaluation of a problem-focused psychosocial intervention for patients with head and neck cancer. Support Care Cancer. 2009;17:379–388.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.22 MB